Market cap
$30 Mln
Revenue (TTM)
$17 Mln
P/E Ratio
--
P/B Ratio
0.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-73 Mln
-
ROE
-1.2 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-0.3
-
Debt to Equity
1.3
-
Book Value
$1.1
-
EPS
$-3
-
Face value
--
-
Shares outstanding
39,763,100
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
IsoPlexis (ISO)
| -50.9 | -23.8 | -53.3 | -79.1 | -- | -- | -- |
|
BSE Sensex*
| -9.2 | -1.4 | 2.8 | -3.7 | 5.7 | 6.2 | 10.5 |
|
Company
|
2022
|
|---|---|
|
IsoPlexis (ISO)
| -83.1 |
|
BSE Sensex
| 4.4 |
|
BSE Sensex
| 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
IsoPlexis (ISO)
|
0.8 | 30.3 | 16.8 | -115.5 | -601.3 | -557.9 | -- | 0.5 |
| 61.5 | 8,018.1 | 616.9 | -75.1 | 1.7 | -9.3 | -- | 10.2 | |
| 14.6 | 9,638.1 | 6,561.1 | -578.0 | -4.5 | -10.3 | -- | 1.7 | |
| 365.1 | 9,761.6 | 2,589.3 | 222.4 | -6.0 | 3 | 44.5 | 1.3 | |
| 57.1 | 8,696.7 | 3,499.6 | -71.2 | 0.5 | -3.2 | -- | 3.8 | |
| 179.9 | 10,905.5 | 612.8 | -188.1 | -30.6 | -28.1 | -- | 16.4 | |
| 100.8 | 6,577.5 | 1,556.3 | 275.3 | 24.6 | 22.9 | 24.1 | 5.0 | |
| 321.7 | 12,752.7 | 1,504.9 | 160.6 | 13.6 | 10.9 | 79.4 | 8.4 | |
| 176.3 | 9,947.9 | 785.1 | 41.5 | 9.9 | 2 | 251.8 | 4.9 | |
| 29.0 | 12,153.4 | 6,164.0 | 625.0 | 13.0 | 11.8 | 19.9 | 2.4 |
Shareholding Pattern
View DetailsAbout IsoPlexis (ISO)
IsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States, Canada, the United Kingdom, Belgium, France, the Czech Republic, Spain, Germany, Sweden,... Italy, Israel, Switzerland, China and Taiwan, Singapore, Japan, Australia, and Korea. The company offers single cell proteomics platform, including instruments, chip consumables, and software that provides an end-to-end solution to view of protein function at an individual cellular level. It provides IsoLight and IsoSpark instruments; IsoCode chips that offer multiplexed chip solutions for single cell functional proteomics; CodePlex chips that provide multiplexed solutions for ultra-low volume bulk samples; and IsoSpeak software that offers dimensional data and automates analysis with an intuitive push button user interface to deliver same day single cell and bulk proteome visualizations, as well as research support and services, and post-warranty services. The company was incorporated in 2013 and is based in Branford, Connecticut. As of March 21, 2023, IsoPlexis Corporation operates as a subsidiary of Berkeley Lights, Inc. Read more
-
Co-Founder, CEO, Pres & Director
Mr. Sean Mackay
-
Co-Founder, CEO, Pres & Director
Mr. Sean Mackay
-
Headquarters
Branford, CT
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for IsoPlexis (ISO)
What is the current share price of IsoPlexis Corporation (ISO) Today?
The share price of IsoPlexis Corporation (ISO) is $0.76 (NASDAQ) as of 27-Mar-2023 09:30 EDT. IsoPlexis Corporation (ISO) has given a return of -79.08% in the last 1 years.
What is the current PB & PE ratio of IsoPlexis Corporation (ISO)?
Since, TTM earnings of IsoPlexis Corporation (ISO) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2022 |
-0.52 |
1.46 |
2021 |
1.21 |
646.07 |
2020 |
-- |
-- |
2019 |
-- |
-- |
2022 |
-0.52 |
1.46 |
What is the 52 Week High and Low of IsoPlexis Corporation (ISO)?
The 52-week high and low of IsoPlexis Corporation (ISO) are Rs -- and Rs -- as of 31-Aug-2026.
What is the market cap of IsoPlexis Corporation (ISO)?
IsoPlexis Corporation (ISO) has a market capitalisation of $ 30 Mln as on 27-Mar-2023. As per SEBI classification, it is a company.
Should I invest in IsoPlexis Corporation (ISO)?
Before investing in IsoPlexis Corporation (ISO), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.